COVID-19-RELATED VACCINES AND THERAPEUTICS;PRELIMINARY INSIGHTS ON RELATED PATENTING ACTIVITY DURING THE PANDEMIC
Since the start of the COVID-19 pandemic there have been remarkable research and innovation efforts to fight the SARS-COV-2 virus and the related disease. This patent landscape report provides early observations on the patenting activity which took place in the field of COVID-19 vaccines and therape...
محفوظ في:
| التنسيق: | الكتروني كتاب الكتروني |
|---|---|
| اللغة: | الإنجليزية |
| منشور في: |
[S.l.] :
WORLD INTELLECTUAL PROPER,
2022.
|
| سلاسل: | Patent landscape report
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | EBSCOhost |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
MARC
| LEADER | 00000cam a2200000M 4500 | ||
|---|---|---|---|
| 001 | on1348286435 | ||
| 003 | OCoLC | ||
| 005 | 20250602105545.0 | ||
| 006 | m d | ||
| 007 | cr ||||||||||| | ||
| 008 | 221021s2022 xx o ||| 0 eng d | ||
| 040 | |a YDX |b eng |c YDX |d SFB |d OCLCQ |d OCLCF |d N$T |d OCLCO |d TMA |d OCLCQ | ||
| 020 | |a 9280533606 |q (electronic bk.) | ||
| 020 | |a 9789280533606 |q (electronic bk.) | ||
| 035 | |a 3709783 |b (N$T) | ||
| 035 | |a (OCoLC)1348286435 | ||
| 050 | 4 | |a RA644.C67 | |
| 082 | 0 | 4 | |a 346.0486 |q OCoLC |2 23/eng/20230216 |
| 049 | |a MAIN | ||
| 245 | 0 | 0 | |a COVID-19-RELATED VACCINES AND THERAPEUTICS;PRELIMINARY INSIGHTS ON RELATED PATENTING ACTIVITY DURING THE PANDEMIC |h [electronic resource]. |
| 260 | |a [S.l.] : |b WORLD INTELLECTUAL PROPER, |c 2022. | ||
| 300 | |a 1 online resource | ||
| 490 | 0 | |a Patent landscape report | |
| 505 | 0 | |a Intro -- _Hlk93048502 -- Acknowledgements -- Key findings -- Introduction -- Background -- biology of COVID-19 -- Overview of patenting activity related to COVID-19 -- Patent filings during 2020-2021 -- Filing and publication of COVID-19-related patent applications over time -- COVID-19-related vaccine and therapeutic patent applicant profiles -- Research collaboration and IP strategies related to technologies important to COVID-19 vaccines and therapeutics -- Disclosure of sequences within patent documents -- COVID-19 vaccines -- Background -- vaccine platforms -- Conventional vaccine platforms -- Novel vaccine platforms -- Patent and vaccine distribution by vaccine platform and published applicant location -- Speed of vaccine development -- COVID-19 vaccine patent landscape -- Core vaccine technologies, collaboration and licensing -- Analysis of WHO data on COVID-19 vaccines -- Timelines on key technologies for COVID-19 vaccine development -- Technologies relevant to mRNA vaccine -- Timeline details for adenovirus vaccine development -- Timeline details for vaccine adjuvant development -- COVID-19 therapeutics -- Background -- Analysis of COVID-19 therapeutics-related patent applications by substances type -- Top locations of patent applicants for COVID-19 therapeutics and their filing strategies -- Highlights of patent filings related to COVID-19 therapeutic development -- Patent filings related to development of small-molecule drugs for COVID-19 -- Patent filings related to the development of biologics for COVID-19 -- Patents related to antibodies for COVID-19 treatment -- Peptide and protein therapies -- Nucleic-acid-based therapies -- Aptamer-mediated therapy -- Cell-based therapies -- Other biologic-based therapies -- Analysis of COVID-19 therapeutics in clinical trials. | |
| 505 | 8 | |a Analysis of COVID-19 therapeutics data in the Milken Institute and Regulatory Affairs Professionals Society (RAPS) tracker data -- Distribution of COVID-19 drug candidates across small molecules and biologics, repurposed drugs and de novo synthesized drugs -- Classification of COVID-19 drug candidates in clinical trials by molecular nature and function -- Feature summary of examples of anti-COVID-19 drug candidates in clinical trials -- Perspectives -- Annex -- Data sources and methods -- Tables of vaccine types and candidates currently in clinical trials -- Examples of partial, early disclosure observed at the Israeli, U.K. and Singapore patent offices -- Glossary -- References -- Further reading. | |
| 520 | |a Since the start of the COVID-19 pandemic there have been remarkable research and innovation efforts to fight the SARS-COV-2 virus and the related disease. This patent landscape report provides early observations on the patenting activity which took place in the field of COVID-19 vaccines and therapeutics, and compares results with clinical trial data for related candidate vaccines and drugs | ||
| 506 | 0 | |a Open Access |5 EbpS | |
| 590 | |a Added to collection customer.56279.3 | ||
| 650 | 0 | |a COVID-19 (Disease) | |
| 650 | 0 | |a Patents. | |
| 650 | 0 | |a Patents (International law) | |
| 650 | 2 | |a COVID-19 | |
| 650 | 6 | |a COVID-19. | |
| 650 | 6 | |a Brevets d'invention (Droit international) | |
| 650 | 7 | |a COVID-19 (Disease) |2 fast | |
| 650 | 7 | |a Patents |2 fast | |
| 650 | 7 | |a Patents (International law) |2 fast | |
| 710 | 2 | |a World Intellectual Property Organization, |e publisher. | |
| 856 | 4 | 0 | |3 EBSCOhost |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=3709783 |
| 938 | |a YBP Library Services |b YANK |n 18177187 | ||
| 938 | |a EBSCOhost |b EBSC |n 3709783 | ||
| 952 | |0 0 |1 0 |2 ddc |4 0 |7 0 |9 4674 |a DL |b DL |d 2025-06-02 |l 0 |r 2025-06-02 10:34:01 |w 2025-06-02 |y PDF | ||
| 994 | |a 92 |b N$T | ||
| 942 | |2 ddc |c PDF |n 0 | ||
| 999 | |c 4254 |d 4254 | ||